ALA Price sensitive 19 Feb 2026, 2:57 PM

Half Year Report and Appendix 4D

Arovella Therapeutics Ltd

No summary is available for this announcement — open the PDF to read it in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in